20 Week Bridging Study in Type II DM
NCT00563225
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus Type II
Interventions
DRUG:
Insulin Glargine
Sponsor
Sanofi